Clinical Trial Update: Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for systemic and tumor-directed therapy in newly diagnosed oligometastatic prostate cancer; results were posted on 2025-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: VA Office of Research and Development | Conditions: Newly Diagnosed Oligometastatic Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-08-01